Machine learning approaches for interpretable antibody property prediction using structural data
By: Kevin Michalewicz, Mauricio Barahona, Barbara Bravi
Potential Business Impact:
Helps design better medicines by understanding body's defenders.
Understanding the relationship between antibody sequence, structure and function is essential for the design of antibody-based therapeutics and research tools. Recently, machine learning (ML) models mostly based on the application of large language models to sequence information have been developed to predict antibody properties. Yet there are open directions to incorporate structural information, not only to enhance prediction but also to offer insights into the underlying molecular mechanisms. This chapter provides an overview of these approaches and describes two ML frameworks that integrate structural data (via graph representations) with neural networks to predict properties of antibodies: ANTIPASTI predicts binding affinity (a global property) whereas INFUSSE predicts residue flexibility (a local property). We survey the principles underpinning these models; the ways in which they encode structural knowledge; and the strategies that can be used to extract biologically relevant statistical signals that can help discover and disentangle molecular determinants of the properties of interest.
Similar Papers
Exploring Protein Language Model Architecture-Induced Biases for Antibody Comprehension
Machine Learning (CS)
Helps design better medicines by understanding body's defense.
Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization
Machine Learning (CS)
Designs better medicines faster using computer models.
Improved Therapeutic Antibody Reformatting through Multimodal Machine Learning
Machine Learning (CS)
Helps doctors make better medicines faster.